Download
00296_2024_Article_5600.pdf 1,61MB
WeightNameValue
1000 Titel
  • The exercise-app Axia for axial spondyloarthritis enhances the home-based exercise frequency in axial spondyloarthritis patients – A cross-sectional survey
1000 Autor/in
  1. Strunz, Patrick-Pascal |
  2. le Maire, Maxime |
  3. Heusinger, Tobias |
  4. Klein, Juliana |
  5. Labinsky, Hannah |
  6. Fleischer, Anna |
  7. Luetkens, Karsten |
  8. Possler , Patricia |
  9. Gernert, Michael |
  10. Leppich, Robert |
  11. Schmieder, Astrid |
  12. Hammel, Ludwig |
  13. Schulz, Evelin |
  14. Sperlich, Billy |
  15. Froehlich, Matthias |
  16. Schmalzing, Marc |
1000 Verlag
  • Springer Berlin Heidelberg
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-04-29
1000 Erschienen in
1000 Quellenangabe
  • 44(6):1143-1154
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00296-024-05600-w |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11108939/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:p>Background: Patients with axial spondyloarthritis (axSpA) benefit from regular home-based exercise (HbE). In spite of recommendations, a relevant proportion of German axSpA patients does not adhere to recommended HbE practices. To enhance HbE care, we developed the novel digital therapeutic (DTx) “Axia” compliant with the European medical device regulation (MDR). Axia offers a modern app-based HbE solution with patient educative content and further integrated features. Objective: We aimed to assess Axia’s efficacy, attractiveness, and functionality through a survey among axSpA-patients involved in the first user tests. Methods: A mixed-method online questionnaire with 38 items was administered to 37 axSpA volunteers after using Axia. Numeric rating scales (NRS) and likelihood scales were primarily used. Results: HbE frequency significantly increased from a median of 1 day/week to 6 days/week (<jats:italic>p</jats:italic> &lt; 0.001) by using Axia. Existing HbE practitioners also increased their frequency (median of 4 days/week before, 6 days/week with Axia, <jats:italic>p</jats:italic> &lt; 0.05). Axia received a median rating of 5 out of 5 stars. On NRS scales, Axia scored a median of 9 for intuitiveness and design, and a median of 8 for entertainment. 64.9% reported improved range of motion, 43.2% reported reduced pain, and 93.6% enhanced disease-specific knowledge. All users recommended Axia to other patients. Conclusion: Axia increases axSpA patients HbE frequency, possibly due to its good intuitiveness and design, leading to reduction in pain and subjective improvement of range of motion. This warrants further investigation in large randomized controlled interventional trials to establish its efficacy conclusively and patients adherence to HbE.</jats:p>
1000 Sacherschließung
lokal Surveys and Questionnaires [MeSH]
lokal Female [MeSH]
lokal Patient Compliance [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Exercise Therapy/methods [MeSH]
lokal Middle Aged [MeSH]
lokal Cross-Sectional Studies [MeSH]
lokal Surveys and questionnaires
lokal Axial Spondyloarthritis [MeSH]
lokal Patient education as topic
lokal Physical therapy modalities
lokal Male [MeSH]
lokal Spondylitis Ankylosing
lokal Mobile Health Units
lokal Germany [MeSH]
lokal Patient Opinion
lokal Mobile Applications [MeSH]
lokal Patient Education as Topic/methods [MeSH]
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-3168-7074|https://orcid.org/0009-0000-1202-8447|https://orcid.org/0009-0002-8883-3404|https://orcid.org/0009-0009-4941-2683|https://orcid.org/0000-0001-5762-9182|https://orcid.org/0009-0009-8760-3931|https://orcid.org/0000-0001-7536-9409|https://orcid.org/0009-0007-1773-4763|https://orcid.org/0000-0003-0074-4459|https://orcid.org/0000-0003-4711-7743|https://orcid.org/0000-0002-6421-9699|https://orcid.org/0009-0003-8403-0652|https://orcid.org/0009-0002-8116-4308|https://orcid.org/0000-0003-4686-8561|https://orcid.org/0000-0001-7745-3903|https://orcid.org/0000-0002-3289-2299
1000 Hinweis
  • DeepGreen-ID: 2bcc4d12bceb43f4acd2f7f78cb18aaa ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Universitätsklinikum Würzburg |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Universitätsklinikum Würzburg |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6490991.rdf
1000 Erstellt am 2025-02-03T13:00:16.070+0100
1000 Erstellt von 322
1000 beschreibt frl:6490991
1000 Zuletzt bearbeitet 2025-07-30T15:14:03.908+0200
1000 Objekt bearb. Wed Jul 30 15:14:03 CEST 2025
1000 Vgl. frl:6490991
1000 Oai Id
  1. oai:frl.publisso.de:frl:6490991 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source